Managed Healthcare Executive July 26, 2024
Higher costs per claim, coupled with an increased number of patients using specialty drugs, has contributed to higher spend.
Specialty drug spend and trend continue an upward with little sign of slowing, according to Pharmaceutical Strategies Group (PSG)’s latest State of Specialty Spend and Trend report, which was sponsored by Walmart Specialty Pharmacy.
Overall, specialty drug trend increased 14% in 2023, according to PSG’s analysis of its clients specialty drug spend. Although claim utilization continues to be the leading driver of specialty drug trend, cost per claim is now playing a substantial role as well
“There are a lot of things happening in the market with specialty drugs,” Renee Rayburg, RPh, vice president of Clinical Strategy at PSG, said in...
Today's Sponsors
Today's Sponsor